Leukoplakia, OSMF and Lichen Planus: Management Focus

Some mouth diseases are not yet cancer but can become it — potentially malignant disorders. The three every dentist must know are leukoplakia (a persistent white patch), oral submucous fibrosis or OSMF (cheek stiffening from areca nut chewing), and oral lichen planus (an immune-driven lace-like white pattern). Together they form most precancers seen in Indian dental clinics.

Catching them early means simple measures — quitting tobacco and areca nut, small excisions, regular review — instead of cancer surgery later. Each has a distinct look, cause and risk, and confusing them leads to wrong treatment.

Key Concepts

• Leukoplakia: an unscrapable white plaque not diagnosable as another disease; tobacco is the main driver; speckled red-white types carry higher risk.
• OSMF: chronic submucosal fibrosis from areca nut (supari, gutka, pan masala); the lining pales and stiffens, opening shrinks, and a notable share turn cancerous over time.
• Oral lichen planus: an immune reaction making white lace-like lines (Wickham's striae), often on both cheeks; the erosive form is painful.
• Wickham's striae: the fine white lacy network marking lichen planus.
• OSMF staging by opening: mild above 35 mm down to severe below 15 mm of maximum opening.
• Dysplasia: biopsy-graded abnormal cell changes (mild, moderate, severe) showing how close a lesion is to cancer.

How It Works

1. Identify the habit. Ask directly about tobacco, gutka, pan masala and areca nut — the cause shapes counselling and diagnosis.
2. Examine and measure. Record size, colour and texture; in suspected OSMF, measure maximum opening in millimetres as baseline.
3. Biopsy for grading. Dysplasia presence and severity — not appearance alone — sets the risk level.
4. Stop the cause. Complete tobacco and areca-nut cessation is the single most effective treatment for all three.
5. Treat the lesion. Excise small dysplastic leukoplakias; OSMF gets intralesional steroids, antioxidants and opening physiotherapy; erosive lichen planus gets topical corticosteroids.
6. Review for life. Follow-up every 3-6 months indefinitely — transformation can come years later.

Worked Example

A 35-year-old man chewing gutka 5 times daily for 10 years has burning with spicy food and opens only 22 mm versus a normal 40 mm — an 18 mm restriction. Pale fibrous bands in both cheeks confirm moderate OSMF. After quitting gutka, he receives intralesional dexamethasone weekly for 6 weeks (6 injections) plus opening exercises, adding one tongue depressor (about 2 mm) per week. At 6 weeks his opening is 30 mm — a gain of 8 mm. He continues home exercises with reviews every 3 months (4 per year) for lifelong surveillance.

Common Misconceptions

• "Tobacco-free pan masala is harmless." Areca nut alone causes OSMF and oral cancer; "tobacco-free" is not safe.
• "Lichen planus is contagious." It is an immune condition, not an infection — it cannot spread by contact.
• "Removing the patch ends the risk." The whole lining faced the carcinogen ("field cancerisation") — follow-up never stops.

Real-World Applications

• Screening camps in high gutka-use regions catching OSMF in teenagers.
• Cessation clinics using visible mouth changes as quitting motivation.
• Oral medicine practices managing erosive lichen planus with topical steroids.

Leukoplakia, OSMF and lichen planus are the mouth's warnings before cancer — each with its own look, cause and treatment, but sharing one first step: stop the tobacco and areca nut. Biopsy to grade risk, treat the lesion, and watch the patient for life — that is how precancer stays precancer.